Compare UPST & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UPST | AMRX |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.0B |
| IPO Year | 2020 | N/A |
| Metric | UPST | AMRX |
|---|---|---|
| Price | $47.32 | $12.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $59.96 | $13.25 |
| AVG Volume (30 Days) | ★ 4.9M | 1.7M |
| Earning Date | 02-10-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | 0.02 |
| Revenue | $997,748,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $56.14 | $9.99 |
| Revenue Next Year | $22.99 | $6.67 |
| P/E Ratio | ★ $183.61 | $691.07 |
| Revenue Growth | ★ 64.93 | 9.50 |
| 52 Week Low | $31.40 | $6.69 |
| 52 Week High | $96.43 | $13.49 |
| Indicator | UPST | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 58.62 |
| Support Level | $43.06 | $12.93 |
| Resistance Level | $51.53 | $13.49 |
| Average True Range (ATR) | 2.43 | 0.29 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 44.47 | 52.38 |
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.